Drugs / Cellerate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03158623 | Apr → Dec 2016 | arthropathy, erosive | Salt Lake Orthopedic Clinic | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellerate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03158623 ↗ |
| Known as | CellerateRX | “two wound additives, Platelet-Rich Plasma (PRP) and CellerateRX® (activated collagen), would improve postoperative wound healing and reduce complications in primary total joint...” NCT03158623 ↗ |